Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Has FDA moved the goalposts?

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Mar 30, 2023 7:04am

173 Views

Post# 35368553

RE:RE:RE:Has FDA moved the goalposts?

Yajne... Always into plot theories?

Weren't you the one that turned into ridicule COVID-19 by stating it was nothing more than a flu and that the government was wasting taxpayers money for nothing on this but that you suddenly requested that the same government should step up its investment in the COVID-19 R&D only once you son ended up catching it and spent 2 days at the hospital in Calgary with respiratory issues? I can quote you on both, if you want to.

As for trials, rules cannot be changed on the fly. That's not even logic. Only one that is into plot theories can think that they could be changed.

<< Previous

Bullboard Posts

Next >>

Critical materials crisis: Diversifying away from China’s monopoly